A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria

Area of Science:

• Vector-borne disease control
• Parasitology
• Drug development

Background:

• Malaria elimination hinges on interrupting disease transmission.
• Current strategies include targeting parasite transmission to mosquitoes or using endectocides to make blood meals toxic.
• Reducing mosquito lifespan is a potential transmission reduction method.

Purpose of the Study:

• To establish a target candidate profile (TCP-6) for developing novel malaria transmission-reducing agents.
• To propose a regulatory strategy for these agents.
• To guide the development and reformulation of endectocides.

Main Methods:

• Analysis of existing endectocides and their properties.
• Utilizing mathematical models of malaria transmission dynamics.
• Incorporating knowledge of vector control impacts.

Main Results:

• A comprehensive target candidate profile (TCP-6) for transmission-reducing agents was developed.
• A strategic regulatory framework was proposed.
• The profile allows assessment of agents based on endectocidal activity, lifespan reduction, or combined effects.

Conclusions:

• The proposed TCP-6 provides a flexible framework for evaluating new malaria transmission-blocking medicines.
• This 'endectocidal transmission blocking' paradigm can assess diverse mechanisms of action.
• The strategy supports the development of novel tools for malaria elimination.